Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1977 Dec;21:121–124. doi: 10.1289/ehp.7721121

Dechloriation mechanisms of chlorinated olefins.

R A Van Dyke
PMCID: PMC1475340  PMID: 612436

Abstract

The dechlorination of chlorinated hydrocarbons has been examined in detail. The reaction is catalyzed by cytochrome P-450 and occurs optimally in the presence of oxygen although some dechlorination may occur under anaerobic conditions. Halothane has been shown to undergo an oxidative dechlorination and a reductive defluorination. Enzymatic attack of chlorinated olefins and hydrocarbons is not on the carbon--halogen bond. Oxidative dechlorination of hydrocarbons is apparently initiated by an attack on the carbon atom and the halogen is then released from the oxidized carbon. The chlorinated olefins, on the other hand, are not easily dechlorinated enzymatically. The chlorines migrate readily across the double bond, therefore, cyclic chloronium ions must occur as intermediates. It is not clear at this time if epoxides are also intermediates in this conversion.

Full text

PDF
121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed A. E., Anders M. W. Metabolism of dihalomethanes to formaldehyde and inorganic halide. I. In vitro studies. Drug Metab Dispos. 1976 Jul-Aug;4(4):357–361. [PubMed] [Google Scholar]
  2. Ahmed A. E., Kubic V. L., Anders M. W. Metabolism of haloforms to carbon monoxide. I. In vitro studies. Drug Metab Dispos. 1977 Mar-Apr;5(2):198–204. [PubMed] [Google Scholar]
  3. BUTLER T. C. Reduction of carbon tetrachloride in vivo and reduction of carbon tetrachloride and chloroform in vitro by tissues and tissue constituents. J Pharmacol Exp Ther. 1961 Dec;134:311–319. [PubMed] [Google Scholar]
  4. Barnsley E. A. The formation of 2-hydroxypropylmercapturic acid from 1-halogenopropanes in the rat. Biochem J. 1966 Aug;100(2):362–372. doi: 10.1042/bj1000362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barr G. A., Cousins M. J., Mazze R. I., Hitt B. A., Kosek J. C. A comparison of the renal effects and metabolism of enflurane and methoxyflurane in Fischer 344 rats. J Pharmacol Exp Ther. 1974 Jan;188(1):257–264. [PubMed] [Google Scholar]
  6. DANIEL J. W. THE METABOLISM OF 36C1-LABELLED TRICHLOROETHYLENE AND TETRACHLOROETHYLENE IN THE RAT. Biochem Pharmacol. 1963 Aug;12:795–802. doi: 10.1016/0006-2952(63)90109-6. [DOI] [PubMed] [Google Scholar]
  7. Gandolfi A. J., Van Dyke R. A. Dechlorination of chloroethane with a reconstituted liver microsomal system. Biochem Biophys Res Commun. 1973 Aug 6;53(3):687–692. doi: 10.1016/0006-291x(73)90148-4. [DOI] [PubMed] [Google Scholar]
  8. Greenstein L. R., Hitt B. A., Mazze R. I. Metabolism in vitro of enflurane, isoflurane, and methoxyflurane. Anesthesiology. 1975 Apr;42(4):420–424. doi: 10.1097/00000542-197504000-00010. [DOI] [PubMed] [Google Scholar]
  9. Henschler D. Metabolism and mutagenicity of halogenated olefins--a comparison of structure and activity. Environ Health Perspect. 1977 Dec;21:61–64. doi: 10.1289/ehp.772161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kubic V. L., Anders M. W., Engel R. R., Barlow C. H., Caughey W. S. Metabolism of dihalomethanes to carbon monoxide. I. In vivo studies. Drug Metab Dispos. 1974 Jan-Feb;2(1):53–57. [PubMed] [Google Scholar]
  11. Leibman K. C. Metabolism of trichloroethylene in liver microsomes. I. Characteristics of the reaction. Mol Pharmacol. 1965 Nov;1(3):239–246. [PubMed] [Google Scholar]
  12. Leibman K. C., Ortiz E. Metabolism of halogenated ethylenes. Environ Health Perspect. 1977 Dec;21:91–97. doi: 10.1289/ehp.772191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Loew G., Trudell J., Motulsky H. Quantum chemical studies of the metabolism of a series of chlorinated ethane anesthetics. Mol Pharmacol. 1973 Mar;9(2):152–162. [PubMed] [Google Scholar]
  14. Rehder K., Forbes J., Alter H., Hessler O., Stier A. Halothane biotransformation in man: a quantitative study. Anesthesiology. 1967 Jul-Aug;28(4):711–715. doi: 10.1097/00000542-196707000-00018. [DOI] [PubMed] [Google Scholar]
  15. Van Dyke R. A., Gandolf A. J. Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents. Drug Metab Dispos. 1976 Jan-Feb;4(1):40–44. [PubMed] [Google Scholar]
  16. Van Dyke R. A., Gandolfi A. J. Characteristics of a microsomal dechlorination system. Mol Pharmacol. 1975 Nov;11(6):809–817. [PubMed] [Google Scholar]
  17. Van Dyke R. A., Wineman C. G. Enzymatic dechlorination. Dechlorination of chloroethanes and propanes in vitro. Biochem Pharmacol. 1971 Feb;20(2):463–470. doi: 10.1016/0006-2952(71)90082-7. [DOI] [PubMed] [Google Scholar]
  18. Van Dyke R. A., Wood C. L. Metabolism of methoxyflurane: release of inorganic fluoride in human and rat hepatic microsomes. Anesthesiology. 1973 Dec;39(6):613–618. [PubMed] [Google Scholar]
  19. Widger L. A., Gandolfi A. J., Van Dyke R. A. Hypoxia and halothane metabolism in vivo: release of inorganic fluoride and halothane metabolite binding to cellular constituents. Anesthesiology. 1976 Mar;44(3):197–201. doi: 10.1097/00000542-197603000-00004. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of American Chemical Society

RESOURCES